Abnova产品 分子生物学仪器

Abnova公司来自中国台湾，是目前世界上zui大的单克隆抗体和蛋白生产商之一，现有抗体数量近4万种，蛋白超过16000种，并具有每月研发500种小鼠单克隆抗体和500种兔源多克隆抗体的技术和实力。与传统抗体生产技术不同，Abnova使用其*的基因组和蛋白质组的方法来制备和生产抗体，其目标是为人类基因组内表达的每一个基因都提供至少一种抗体。Abnova生产的所有产品，重组蛋白和抗体均采用目前上的生产和SPF级动物设施。和传统的单克隆抗体生产方法相比，Abnova采用更*的蛋白生产技术和设备，可以极大地提高单克隆抗体的生产效率并降低其生产的成本。其的小麦胚芽体外蛋白表达系统（Wheat Germ In Vitro Protein Expression System），利用小麦胚芽萃取物可高效率执行体外mRNA翻译蛋白质的特点，快速生产高品质和功能高度相似的蛋白质，能更有效的用于生产抗体尤其适合于制备功能蛋白并用于生产抗体。MaxPab□技术是Abnova的抗体生产技术，其生产的抗体能双重识别蛋白一级结构及三级结构的抗原表位，非常适合用于免疫学检测，具有高反应性、高灵敏性和高特异性的特点。Abnova对所生产的产品提供的质量保证（说明书验证的实验方法和种属），让您无忧无虑使用抗体：
Abnova是世界上zui大的单克隆抗体生产商之一，现有抗体产品种类近30000种，其中2/3是单克隆抗体。和传统的单克隆抗体生产方法相比，Abnova采用更*的技术和设备，可以极大地提高单克隆抗体的生产效率并降低其生产的成本。Abnova具有每个月开发500个小鼠单克隆抗体的能力，他们的目标是：人类基因组中的每一个表达基因都至少有一种抗体。

The Gap between Genomics and Proteomics

After the completion of human genomic project, most human expressed genes have been identified, and full-length cDNA of these genes have become publicly available. In the emerging proteomics era, proteins act as the key players in the unveiling of these genes. In order to effectively decipher the mystery of these proteins, antibodies with their inherent sensitivity and specificity thus become the most versatile tools for providing one-to-one relationship with their target proteins. 

What Abnova Does

The mission of Abnova is to become a leader in high throughput antibody and protein production. Abnova intends to become worlds largest protein and antibody catalog company by building a full collection of essential proteins and their antibodies targeting the human genome.  

Why Choose Abnova?

Abnova offers a unique complete monoclonal antibody and protein experience for our customer that is different from traditional custom production companies and laboratories.

Industrial-Scale Infrastructure: We maintain a streamlined monoclonal production facility with scalable capacity for up to 500 immunization per month, and a state-of-the-art specific pathogen free （SPF） facility, which has the breeding and holding capacity for 10,000+ mice. These facilities allow us to significantly bring down the cost of customized monoclonal antibody production. We have also incorporated numerous automation systems into our production line, which significantly increased our efficiency.

Wheat Germ In Vitro Protein Expression System: We have a high throughput protein production system, which allows soluble expression of conformational correct protein either from full-length cDNA or specific domains.